Endurant Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-13,193
Closed -$2.67M 57
2020
Q1
$2.67M Buy
+13,193
New +$2.88M 1.21% 23
2017
Q1
Sell
-4,358
Closed -$637K 90
2016
Q4
$637K Sell
4,358
-3,500
-45% -$527K 0.26% 62
2016
Q3
$1.31M Sell
7,858
-18,442
-70% -$3.12M 0.49% 47
2016
Q2
$4M Buy
26,300
+20,700
+370% +$3.22M 1.34% 26
2016
Q1
$840K Buy
+5,600
New +$832K 0.27% 59
2015
Q4
Sell
-15,800
Closed -$2.19M 78
2015
Q3
$2.19M Buy
15,800
+6,600
+72% +$1.04M 0.73% 43
2015
Q2
$1.41M Buy
9,200
+7,100
+338% +$1.14M 0.42% 55
2015
Q1
$336K Buy
+2,100
New +$331K 0.11% 88

Other funds holding AMGN

Endurant Capital Management's AMGN Position: Q2 2020 in Review

Endurant Capital Management sold out of Amgen (AMGN) in Q2 2020, closing a stake of 13,193 shares — an estimated $2.67M sold.

Endurant Capital Management first reported a position in AMGN in Q1 2015 and held it in 8 quarters. The position peaked at $4M in Q2 2016. 2,090 funds tracked by Wall St. Rank hold AMGN as of Q2 2020.

  • Endurant Capital Management reported no remaining Amgen position as of Q2 2020 after selling out during the quarter.
  • Endurant Capital Management sold 13,193 Amgen shares in Q2 2020, an estimated $2.67M.
  • Endurant Capital Management first reported a position in Amgen in Q1 2015 and held it in 8 quarters.
  • Endurant Capital Management's Amgen position peaked at $4M in Q2 2016.
  • 2,090 funds tracked by Wall St. Rank held Amgen as of Q2 2020.

Based on Endurant Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.